Journal article · 2017 · Open access

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

Ömer Toprak, Hüseyin Kurt, Yasin Sarı, Cihat Şarkış, Halil Us, Ali Kırık

Kidney & Blood Pressure Research, 42(1), 33–42 · Published 1 January 2017 · DOI 10.1159/000468530

Read the free full textCite this paper

In brief

“Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study” is a 2017 journal article by Ömer Toprak and 5 co-authors, published in Kidney & Blood Pressure Research. OpenAlex counts 29,772 citations as of 15 November 2026, which puts it in the top 2% of works published in 2017 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Kidney & Blood Pressure Research.

Citations
29,772
Most cited in
2022 (3,287)
Field-weighted impact
1863.99
References
75
Authors
6

Abstract

BACKGROUND/AIMS: Magnesium is an essential mineral for many metabolic functions. There is very little information on the effect of magnesium supplementation on metabolic profiles of chronic kidney disease (CKD) patients. The aim of this study was to assess the influence of magnesium supplementation on metabolic profiles of pre-diabetic, obese and mild-to-moderate CKD patients with hypomagnesemia. METHODS: A total of 128 hypomagnesemic, pre-diabetic and obese patients with an estimated glomerular filtration rate between 90 and 30 ml/min/1.73m2 were enrolled in a randomised, double-blind, placebo-controlled trial. Patients in the magnesium group received 365 mg of oral magnesium (n = 57) once daily for 3 months, while patients in the control group received a placebo (n = 61), also once daily for 3 months. Hypomagnesemia is defined by a serum magnesium level <1.8 mg/dl in males and <1.9 mg/dl in females; obesity is defined as a body mass index ≥30 kg/m2; and pre-diabetes is defined as fasting plasma glucose ≥100 but <126 mg/dl. The primary end point of the study was the change in insulin resistance measured by the homeostastic model assessment for insulin resistance (HOMA-IR). RESULTS: At the end of follow-up, insulin resistance (-24.5 vs. -8.2%, P = 0.007), HOMA-IR index (-31.9 vs. -3.3%, P < 0.001), hemoglobin A1c (-6.6 vs. -0.16%, P < 0.001), insulin (-29.6 vs. -2.66%, P < 0.001), waist circumference (-4.8 vs. 0.55%, P < 0.001) and uric acid (-0.8 vs. 2.2%, P = 0.004) were significantly decreased in terms of mean changes; albumin (0.91 vs. -2.91%, P = 0.007) and magnesium (0.21 ± 0.18 vs. -0.04 ± 0.05 mg/dl, P < 0.001) were significantly increased in those taking magnesium compared with a placebo. The decrease in metabolic syndrome (-10.5 vs. -4.9%, P = 0.183), obesity (-15.7 vs. -8.2%, P = 0.131), pre-diabetes (-17.5 vs. -9.8%, P = 0.140), and systolic (-5.0 ± 14.8 vs. 0.22 ± 14.9 mm Hg, P = 0.053) and diastolic (-3.07 ± 9.7 vs. 0.07 ± 9.6 mm Hg, P = 0.071) blood pressure did not achieve to a significant level after study. CONCLUSION: Our data support the argument that magnesium supplementation improves the metabolic status in hypomagnesemic CKD patients with pre-diabetes and obesity.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017). Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study. Kidney & Blood Pressure Research, 42(1), 33–42. https://doi.org/10.1159/000468530

MLA 9

Toprak, Ömer, et al. “Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.” Kidney & Blood Pressure Research, vol. 42, no. 1, 2017, pp. 33–42. https://doi.org/10.1159/000468530.

Chicago

Toprak, Ömer, Hüseyin Kurt, Yasin Sarı, Cihat Şarkış, Halil Us, and Ali Kırık. 2017. “Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.” Kidney & Blood Pressure Research 42 (1): 33–42. https://doi.org/10.1159/000468530.

Harvard

Toprak, Ö. et al. (2017) ‘Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study’, Kidney & Blood Pressure Research, 42(1), pp. 33–42. doi:10.1159/000468530.

IEEE

Ö. Toprak, H. Kurt, Y. Sarı, C. Şarkış, H. Us, and A. Kırık, “Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study,” Kidney & Blood Pressure Research, vol. 42, no. 1, pp. 33–42, 2017, doi: 10.1159/000468530.

BibTeX

@article{toprak2017magnesium,
  title     = {{Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study}},
  author    = {Toprak, Ömer and Kurt, Hüseyin and Sarı, Yasin and Şarkış, Cihat and Us, Halil and Kırık, Ali},
  journal   = {Kidney \& Blood Pressure Research},
  year      = {2017},
  volume    = {42},
  number    = {1},
  pages     = {33--42},
  doi       = {10.1159/000468530},
  url       = {https://doi.org/10.1159/000468530}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20172,4352435
20182,2502250
20192,1632163
20201,7761776
20212,1952195
20223,2873287
20232,9022902
20242,4062406
2025882882
202666

Its field-weighted citation impact is 1863.99: it has been cited 1863.99 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease

  • magnesium supplementation
  • hypomagnesemia
  • chronic kidney disease
  • obesity
  • prediabetes
  • insulin resistance
  • HOMA-IR
  • metabolic profile

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017). Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study. Kidney & Blood Pressure Research, 42(1), 33–42. https://doi.org/10.1159/000468530

How many times has this paper been cited?

29,772 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Kidney & Blood Pressure Research.

Who wrote this paper?

Ömer Toprak, Hüseyin Kurt, Yasin Sarı, Cihat Şarkış, Halil Us, Ali Kırık.

What is the DOI of this paper?

10.1159/000468530. The permanent link is https://doi.org/10.1159/000468530.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.